Selected article for: "GH growth hormone and growth hormone"
Author: Lubrano, Carla; Masi, Davide; Risi, Renata; Balena, Angela; Watanabe, Mikiko; Mariani, Stefania; Gnessi, Lucio
Title: Is growth hormone insufficiency the missing link between obesity, male gender, age and COVID‐19 severity?
  • Cord-id: 3itp6vvs
  • Document date: 2020_8_17
    • ID: 3itp6vvs
    Snippet: Evidence has lately emerged regarding an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with worse prognosis in elderly male patients with obesity, and a blunted Growth Hormone (GH) secretion represents a feature of this population subgroup. Here we offer a comprehensive review of the possible links between GH‐Insulin‐like Growth Factor 1 (IGF1) axis impairment and CoronaVirus Disease 2019 (COVID‐19) severity. First, unequivocal evidence suggest that imm
    Document: Evidence has lately emerged regarding an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with worse prognosis in elderly male patients with obesity, and a blunted Growth Hormone (GH) secretion represents a feature of this population subgroup. Here we offer a comprehensive review of the possible links between GH‐Insulin‐like Growth Factor 1 (IGF1) axis impairment and CoronaVirus Disease 2019 (COVID‐19) severity. First, unequivocal evidence suggest that immune system dysregulation represents a key element in determining SARS‐CoV‐2 severity, as well as being associated with adult‐onset GH deficiency (GHD); notably, if GH is physiologically involved in the development and maintenance of the immune system, its pharmacological replacement in GHD patients seems to positively influence their inflammatory status. In addition, the impaired fibrinolysis associated with GHD, may represent a further link between GH‐IGF1 axis impairment and COVID‐19 severity, as it has been associated with both conditions. In conclusion, several evidences support a relationship between GHD and COVID‐19, and they also shed a light upon potential beneficial effects of recombinant GH treatment on COVID‐19 patients.

    Search related documents:
    Co phrase search for related documents
    • abdominal fat and lung function: 1, 2
    • accepted article and acute respiratory syndrome sars: 1, 2, 3, 4, 5
    • acute phase and long administration: 1
    • acute phase and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute phase and lung development: 1, 2, 3, 4
    • acute phase and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute phase and lung function improve: 1
    • acute phase and lung volume: 1, 2, 3, 4, 5, 6
    • acute phase and macrophage polarization: 1
    • acute respiratory syndrome sars and long administration: 1, 2
    • acute respiratory syndrome sars and lung beneficial effect: 1
    • acute respiratory syndrome sars and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome sars and lung development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome sars and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome sars and lung function improve: 1, 2, 3, 4
    • acute respiratory syndrome sars and lung volume: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome sars and macrophage polarization: 1, 2, 3
    • lung damage and macrophage polarization: 1, 2, 3, 4
    • lung development and macrophage polarization: 1